Clinical Research Trials Archive – Closed Trials

This is our archive of closed clinical trials, which means that they are no longer accepting new participants or have been concluded. Once a research facility has chosen to close the study, it is sorted into the GPS archive by indication. If you are interested in enrolling in a clinical trial, then please browse our list of active clinical studies.

Zip code

Condition


Search Radius:25 Miles
  • 5
  • 10
  • 15
  • 20
  • 25
  • 30
  • 40
  • 50
  • 100
  • 500
  • All

We've found
1,011
archived clinical trials in
Postmenopausal Syndrome

A Study of Ibandronate (Boniva) to Evaluate Satisfaction in Women With Post-Menopausal Osteoporosis or Osteopenia
A Prospective, Open-Label, Multi-Center, Two-Part Study to Investigate Patient Satisfaction With Monthly Dosed Ibandronate Therapy in Women With Post-Menopausal Osteoporosis or Osteopenia Transitioned From Once-Weekly Alendronate or Risendronate
Status: Enrolling
Updated:  8/1/2016
Clinical Research Facility
mi
from
Denton, TX
A Study of Ibandronate (Boniva) to Evaluate Satisfaction in Women With Post-Menopausal Osteoporosis or Osteopenia
A Prospective, Open-Label, Multi-Center, Two-Part Study to Investigate Patient Satisfaction With Monthly Dosed Ibandronate Therapy in Women With Post-Menopausal Osteoporosis or Osteopenia Transitioned From Once-Weekly Alendronate or Risendronate
Status: Enrolling
Updated: 8/1/2016
Clinical Research Facility
mi
from
Denton, TX
Click here to add this to my saved trials
A Study of Ibandronate (Boniva) to Evaluate Satisfaction in Women With Post-Menopausal Osteoporosis or Osteopenia
A Prospective, Open-Label, Multi-Center, Two-Part Study to Investigate Patient Satisfaction With Monthly Dosed Ibandronate Therapy in Women With Post-Menopausal Osteoporosis or Osteopenia Transitioned From Once-Weekly Alendronate or Risendronate
Status: Enrolling
Updated:  8/1/2016
Clinical Research Facility
mi
from
San Antonio, TX
A Study of Ibandronate (Boniva) to Evaluate Satisfaction in Women With Post-Menopausal Osteoporosis or Osteopenia
A Prospective, Open-Label, Multi-Center, Two-Part Study to Investigate Patient Satisfaction With Monthly Dosed Ibandronate Therapy in Women With Post-Menopausal Osteoporosis or Osteopenia Transitioned From Once-Weekly Alendronate or Risendronate
Status: Enrolling
Updated: 8/1/2016
Clinical Research Facility
mi
from
San Antonio, TX
Click here to add this to my saved trials
A Study of Ibandronate (Boniva) to Evaluate Satisfaction in Women With Post-Menopausal Osteoporosis or Osteopenia
A Prospective, Open-Label, Multi-Center, Two-Part Study to Investigate Patient Satisfaction With Monthly Dosed Ibandronate Therapy in Women With Post-Menopausal Osteoporosis or Osteopenia Transitioned From Once-Weekly Alendronate or Risendronate
Status: Enrolling
Updated:  8/1/2016
Clinical Research Facility
mi
from
Wichita Falls, TX
A Study of Ibandronate (Boniva) to Evaluate Satisfaction in Women With Post-Menopausal Osteoporosis or Osteopenia
A Prospective, Open-Label, Multi-Center, Two-Part Study to Investigate Patient Satisfaction With Monthly Dosed Ibandronate Therapy in Women With Post-Menopausal Osteoporosis or Osteopenia Transitioned From Once-Weekly Alendronate or Risendronate
Status: Enrolling
Updated: 8/1/2016
Clinical Research Facility
mi
from
Wichita Falls, TX
Click here to add this to my saved trials
A Study of Ibandronate (Boniva) to Evaluate Satisfaction in Women With Post-Menopausal Osteoporosis or Osteopenia
A Prospective, Open-Label, Multi-Center, Two-Part Study to Investigate Patient Satisfaction With Monthly Dosed Ibandronate Therapy in Women With Post-Menopausal Osteoporosis or Osteopenia Transitioned From Once-Weekly Alendronate or Risendronate
Status: Enrolling
Updated:  8/1/2016
Clinical Research Facility
mi
from
Norfolk, VA
A Study of Ibandronate (Boniva) to Evaluate Satisfaction in Women With Post-Menopausal Osteoporosis or Osteopenia
A Prospective, Open-Label, Multi-Center, Two-Part Study to Investigate Patient Satisfaction With Monthly Dosed Ibandronate Therapy in Women With Post-Menopausal Osteoporosis or Osteopenia Transitioned From Once-Weekly Alendronate or Risendronate
Status: Enrolling
Updated: 8/1/2016
Clinical Research Facility
mi
from
Norfolk, VA
Click here to add this to my saved trials
A Study of Ibandronate (Boniva) to Evaluate Satisfaction in Women With Post-Menopausal Osteoporosis or Osteopenia
A Prospective, Open-Label, Multi-Center, Two-Part Study to Investigate Patient Satisfaction With Monthly Dosed Ibandronate Therapy in Women With Post-Menopausal Osteoporosis or Osteopenia Transitioned From Once-Weekly Alendronate or Risendronate
Status: Enrolling
Updated:  8/1/2016
Clinical Research Facility
mi
from
Richmond, VA
A Study of Ibandronate (Boniva) to Evaluate Satisfaction in Women With Post-Menopausal Osteoporosis or Osteopenia
A Prospective, Open-Label, Multi-Center, Two-Part Study to Investigate Patient Satisfaction With Monthly Dosed Ibandronate Therapy in Women With Post-Menopausal Osteoporosis or Osteopenia Transitioned From Once-Weekly Alendronate or Risendronate
Status: Enrolling
Updated: 8/1/2016
Clinical Research Facility
mi
from
Richmond, VA
Click here to add this to my saved trials
A Study of Ibandronate (Boniva) to Evaluate Satisfaction in Women With Post-Menopausal Osteoporosis or Osteopenia
A Prospective, Open-Label, Multi-Center, Two-Part Study to Investigate Patient Satisfaction With Monthly Dosed Ibandronate Therapy in Women With Post-Menopausal Osteoporosis or Osteopenia Transitioned From Once-Weekly Alendronate or Risendronate
Status: Enrolling
Updated:  8/1/2016
Clinical Research Facility
mi
from
Renton, WA
A Study of Ibandronate (Boniva) to Evaluate Satisfaction in Women With Post-Menopausal Osteoporosis or Osteopenia
A Prospective, Open-Label, Multi-Center, Two-Part Study to Investigate Patient Satisfaction With Monthly Dosed Ibandronate Therapy in Women With Post-Menopausal Osteoporosis or Osteopenia Transitioned From Once-Weekly Alendronate or Risendronate
Status: Enrolling
Updated: 8/1/2016
Clinical Research Facility
mi
from
Renton, WA
Click here to add this to my saved trials
A Study of Ibandronate (Boniva) to Evaluate Satisfaction in Women With Post-Menopausal Osteoporosis or Osteopenia
A Prospective, Open-Label, Multi-Center, Two-Part Study to Investigate Patient Satisfaction With Monthly Dosed Ibandronate Therapy in Women With Post-Menopausal Osteoporosis or Osteopenia Transitioned From Once-Weekly Alendronate or Risendronate
Status: Enrolling
Updated:  8/1/2016
Clinical Research Facility
mi
from
Seattle, WA
A Study of Ibandronate (Boniva) to Evaluate Satisfaction in Women With Post-Menopausal Osteoporosis or Osteopenia
A Prospective, Open-Label, Multi-Center, Two-Part Study to Investigate Patient Satisfaction With Monthly Dosed Ibandronate Therapy in Women With Post-Menopausal Osteoporosis or Osteopenia Transitioned From Once-Weekly Alendronate or Risendronate
Status: Enrolling
Updated: 8/1/2016
Clinical Research Facility
mi
from
Seattle, WA
Click here to add this to my saved trials
A Study of Ibandronate (Boniva) to Evaluate Satisfaction in Women With Post-Menopausal Osteoporosis or Osteopenia
A Prospective, Open-Label, Multi-Center, Two-Part Study to Investigate Patient Satisfaction With Monthly Dosed Ibandronate Therapy in Women With Post-Menopausal Osteoporosis or Osteopenia Transitioned From Once-Weekly Alendronate or Risendronate
Status: Enrolling
Updated:  8/1/2016
Clinical Research Facility
mi
from
Spokane, WA
A Study of Ibandronate (Boniva) to Evaluate Satisfaction in Women With Post-Menopausal Osteoporosis or Osteopenia
A Prospective, Open-Label, Multi-Center, Two-Part Study to Investigate Patient Satisfaction With Monthly Dosed Ibandronate Therapy in Women With Post-Menopausal Osteoporosis or Osteopenia Transitioned From Once-Weekly Alendronate or Risendronate
Status: Enrolling
Updated: 8/1/2016
Clinical Research Facility
mi
from
Spokane, WA
Click here to add this to my saved trials
A Study of Ibandronate (Boniva) to Evaluate Satisfaction in Women With Post-Menopausal Osteoporosis or Osteopenia
A Prospective, Open-Label, Multi-Center, Two-Part Study to Investigate Patient Satisfaction With Monthly Dosed Ibandronate Therapy in Women With Post-Menopausal Osteoporosis or Osteopenia Transitioned From Once-Weekly Alendronate or Risendronate
Status: Enrolling
Updated:  8/1/2016
Clinical Research Facility
mi
from
Tacoma, WA
A Study of Ibandronate (Boniva) to Evaluate Satisfaction in Women With Post-Menopausal Osteoporosis or Osteopenia
A Prospective, Open-Label, Multi-Center, Two-Part Study to Investigate Patient Satisfaction With Monthly Dosed Ibandronate Therapy in Women With Post-Menopausal Osteoporosis or Osteopenia Transitioned From Once-Weekly Alendronate or Risendronate
Status: Enrolling
Updated: 8/1/2016
Clinical Research Facility
mi
from
Tacoma, WA
Click here to add this to my saved trials
A Study of Ibandronate (Boniva) to Evaluate Satisfaction in Women With Post-Menopausal Osteoporosis or Osteopenia
A Prospective, Open-Label, Multi-Center, Two-Part Study to Investigate Patient Satisfaction With Monthly Dosed Ibandronate Therapy in Women With Post-Menopausal Osteoporosis or Osteopenia Transitioned From Once-Weekly Alendronate or Risendronate
Status: Enrolling
Updated:  8/1/2016
Clinical Research Facility
mi
from
Madison, WI
A Study of Ibandronate (Boniva) to Evaluate Satisfaction in Women With Post-Menopausal Osteoporosis or Osteopenia
A Prospective, Open-Label, Multi-Center, Two-Part Study to Investigate Patient Satisfaction With Monthly Dosed Ibandronate Therapy in Women With Post-Menopausal Osteoporosis or Osteopenia Transitioned From Once-Weekly Alendronate or Risendronate
Status: Enrolling
Updated: 8/1/2016
Clinical Research Facility
mi
from
Madison, WI
Click here to add this to my saved trials
A Study of Ibandronate (Boniva) to Evaluate Satisfaction in Women With Post-Menopausal Osteoporosis or Osteopenia
A Prospective, Open-Label, Multi-Center, Two-Part Study to Investigate Patient Satisfaction With Monthly Dosed Ibandronate Therapy in Women With Post-Menopausal Osteoporosis or Osteopenia Transitioned From Once-Weekly Alendronate or Risendronate
Status: Enrolling
Updated:  8/1/2016
Clinical Research Facility
mi
from
Milwaukee, WI
A Study of Ibandronate (Boniva) to Evaluate Satisfaction in Women With Post-Menopausal Osteoporosis or Osteopenia
A Prospective, Open-Label, Multi-Center, Two-Part Study to Investigate Patient Satisfaction With Monthly Dosed Ibandronate Therapy in Women With Post-Menopausal Osteoporosis or Osteopenia Transitioned From Once-Weekly Alendronate or Risendronate
Status: Enrolling
Updated: 8/1/2016
Clinical Research Facility
mi
from
Milwaukee, WI
Click here to add this to my saved trials
Acute Effect of Teriparatide With Bisphosphonate or Denosumab on Bone Resorption
Acute Effect of Teriparatide With Bisphosphonate or Denosumab on Bone Resorption
Status: Enrolling
Updated:  11/30/2016
Massachusetts General Hospital
mi
from
Boston, MA
Acute Effect of Teriparatide With Bisphosphonate or Denosumab on Bone Resorption
Acute Effect of Teriparatide With Bisphosphonate or Denosumab on Bone Resorption
Status: Enrolling
Updated: 11/30/2016
Massachusetts General Hospital
mi
from
Boston, MA
Click here to add this to my saved trials
A Double-blind Study to Assess the Efficacy and Safety of Denosumab Produced by Two Different Processes in Postmenopausal Women With Osteoporosis
A Multicenter, Double-blind, Randomized Study to Assess the Efficacy and Safety of Denosumab Produced by Two Different Processes in Postmenopausal Women With Osteoporosis
Status: Enrolling
Updated:  4/11/2017
Clinical Research Facility
mi
from
Santa Maria, CA
A Double-blind Study to Assess the Efficacy and Safety of Denosumab Produced by Two Different Processes in Postmenopausal Women With Osteoporosis
A Multicenter, Double-blind, Randomized Study to Assess the Efficacy and Safety of Denosumab Produced by Two Different Processes in Postmenopausal Women With Osteoporosis
Status: Enrolling
Updated: 4/11/2017
Clinical Research Facility
mi
from
Santa Maria, CA
Click here to add this to my saved trials
A Double-blind Study to Assess the Efficacy and Safety of Denosumab Produced by Two Different Processes in Postmenopausal Women With Osteoporosis
A Multicenter, Double-blind, Randomized Study to Assess the Efficacy and Safety of Denosumab Produced by Two Different Processes in Postmenopausal Women With Osteoporosis
Status: Enrolling
Updated:  4/11/2017
Clinical Research Facility
mi
from
South Lake Tahoe, CA
A Double-blind Study to Assess the Efficacy and Safety of Denosumab Produced by Two Different Processes in Postmenopausal Women With Osteoporosis
A Multicenter, Double-blind, Randomized Study to Assess the Efficacy and Safety of Denosumab Produced by Two Different Processes in Postmenopausal Women With Osteoporosis
Status: Enrolling
Updated: 4/11/2017
Clinical Research Facility
mi
from
South Lake Tahoe, CA
Click here to add this to my saved trials
A Double-blind Study to Assess the Efficacy and Safety of Denosumab Produced by Two Different Processes in Postmenopausal Women With Osteoporosis
A Multicenter, Double-blind, Randomized Study to Assess the Efficacy and Safety of Denosumab Produced by Two Different Processes in Postmenopausal Women With Osteoporosis
Status: Enrolling
Updated:  4/11/2017
Clinical Research Facility
mi
from
Lakewood, CO
A Double-blind Study to Assess the Efficacy and Safety of Denosumab Produced by Two Different Processes in Postmenopausal Women With Osteoporosis
A Multicenter, Double-blind, Randomized Study to Assess the Efficacy and Safety of Denosumab Produced by Two Different Processes in Postmenopausal Women With Osteoporosis
Status: Enrolling
Updated: 4/11/2017
Clinical Research Facility
mi
from
Lakewood, CO
Click here to add this to my saved trials
A Double-blind Study to Assess the Efficacy and Safety of Denosumab Produced by Two Different Processes in Postmenopausal Women With Osteoporosis
A Multicenter, Double-blind, Randomized Study to Assess the Efficacy and Safety of Denosumab Produced by Two Different Processes in Postmenopausal Women With Osteoporosis
Status: Enrolling
Updated:  4/11/2017
Clinical Research Facility
mi
from
Gainesville, GA
A Double-blind Study to Assess the Efficacy and Safety of Denosumab Produced by Two Different Processes in Postmenopausal Women With Osteoporosis
A Multicenter, Double-blind, Randomized Study to Assess the Efficacy and Safety of Denosumab Produced by Two Different Processes in Postmenopausal Women With Osteoporosis
Status: Enrolling
Updated: 4/11/2017
Clinical Research Facility
mi
from
Gainesville, GA
Click here to add this to my saved trials
A Double-blind Study to Assess the Efficacy and Safety of Denosumab Produced by Two Different Processes in Postmenopausal Women With Osteoporosis
A Multicenter, Double-blind, Randomized Study to Assess the Efficacy and Safety of Denosumab Produced by Two Different Processes in Postmenopausal Women With Osteoporosis
Status: Enrolling
Updated:  4/11/2017
Clinical Research Facility
mi
from
Bethesda, MD
A Double-blind Study to Assess the Efficacy and Safety of Denosumab Produced by Two Different Processes in Postmenopausal Women With Osteoporosis
A Multicenter, Double-blind, Randomized Study to Assess the Efficacy and Safety of Denosumab Produced by Two Different Processes in Postmenopausal Women With Osteoporosis
Status: Enrolling
Updated: 4/11/2017
Clinical Research Facility
mi
from
Bethesda, MD
Click here to add this to my saved trials
A Double-blind Study to Assess the Efficacy and Safety of Denosumab Produced by Two Different Processes in Postmenopausal Women With Osteoporosis
A Multicenter, Double-blind, Randomized Study to Assess the Efficacy and Safety of Denosumab Produced by Two Different Processes in Postmenopausal Women With Osteoporosis
Status: Enrolling
Updated:  4/11/2017
Clinical Research Facility
mi
from
Detroit, MI
A Double-blind Study to Assess the Efficacy and Safety of Denosumab Produced by Two Different Processes in Postmenopausal Women With Osteoporosis
A Multicenter, Double-blind, Randomized Study to Assess the Efficacy and Safety of Denosumab Produced by Two Different Processes in Postmenopausal Women With Osteoporosis
Status: Enrolling
Updated: 4/11/2017
Clinical Research Facility
mi
from
Detroit, MI
Click here to add this to my saved trials
A Double-blind Study to Assess the Efficacy and Safety of Denosumab Produced by Two Different Processes in Postmenopausal Women With Osteoporosis
A Multicenter, Double-blind, Randomized Study to Assess the Efficacy and Safety of Denosumab Produced by Two Different Processes in Postmenopausal Women With Osteoporosis
Status: Enrolling
Updated:  4/11/2017
Clinical Research Facility
mi
from
Albuquerque, NM
A Double-blind Study to Assess the Efficacy and Safety of Denosumab Produced by Two Different Processes in Postmenopausal Women With Osteoporosis
A Multicenter, Double-blind, Randomized Study to Assess the Efficacy and Safety of Denosumab Produced by Two Different Processes in Postmenopausal Women With Osteoporosis
Status: Enrolling
Updated: 4/11/2017
Clinical Research Facility
mi
from
Albuquerque, NM
Click here to add this to my saved trials
A Double-blind Study to Assess the Efficacy and Safety of Denosumab Produced by Two Different Processes in Postmenopausal Women With Osteoporosis
A Multicenter, Double-blind, Randomized Study to Assess the Efficacy and Safety of Denosumab Produced by Two Different Processes in Postmenopausal Women With Osteoporosis
Status: Enrolling
Updated:  4/11/2017
Clinical Research Facility
mi
from
Akron, OH
A Double-blind Study to Assess the Efficacy and Safety of Denosumab Produced by Two Different Processes in Postmenopausal Women With Osteoporosis
A Multicenter, Double-blind, Randomized Study to Assess the Efficacy and Safety of Denosumab Produced by Two Different Processes in Postmenopausal Women With Osteoporosis
Status: Enrolling
Updated: 4/11/2017
Clinical Research Facility
mi
from
Akron, OH
Click here to add this to my saved trials
A Double-blind Study to Assess the Efficacy and Safety of Denosumab Produced by Two Different Processes in Postmenopausal Women With Osteoporosis
A Multicenter, Double-blind, Randomized Study to Assess the Efficacy and Safety of Denosumab Produced by Two Different Processes in Postmenopausal Women With Osteoporosis
Status: Enrolling
Updated:  4/11/2017
Clinical Research Facility
mi
from
Bend, OR
A Double-blind Study to Assess the Efficacy and Safety of Denosumab Produced by Two Different Processes in Postmenopausal Women With Osteoporosis
A Multicenter, Double-blind, Randomized Study to Assess the Efficacy and Safety of Denosumab Produced by Two Different Processes in Postmenopausal Women With Osteoporosis
Status: Enrolling
Updated: 4/11/2017
Clinical Research Facility
mi
from
Bend, OR
Click here to add this to my saved trials
A Double-blind Study to Assess the Efficacy and Safety of Denosumab Produced by Two Different Processes in Postmenopausal Women With Osteoporosis
A Multicenter, Double-blind, Randomized Study to Assess the Efficacy and Safety of Denosumab Produced by Two Different Processes in Postmenopausal Women With Osteoporosis
Status: Enrolling
Updated:  4/11/2017
Clinical Research Facility
mi
from
Duncansville, PA
A Double-blind Study to Assess the Efficacy and Safety of Denosumab Produced by Two Different Processes in Postmenopausal Women With Osteoporosis
A Multicenter, Double-blind, Randomized Study to Assess the Efficacy and Safety of Denosumab Produced by Two Different Processes in Postmenopausal Women With Osteoporosis
Status: Enrolling
Updated: 4/11/2017
Clinical Research Facility
mi
from
Duncansville, PA
Click here to add this to my saved trials
A Double-blind Study to Assess the Efficacy and Safety of Denosumab Produced by Two Different Processes in Postmenopausal Women With Osteoporosis
A Multicenter, Double-blind, Randomized Study to Assess the Efficacy and Safety of Denosumab Produced by Two Different Processes in Postmenopausal Women With Osteoporosis
Status: Enrolling
Updated:  4/11/2017
mi
from
Vancouver,
A Double-blind Study to Assess the Efficacy and Safety of Denosumab Produced by Two Different Processes in Postmenopausal Women With Osteoporosis
A Multicenter, Double-blind, Randomized Study to Assess the Efficacy and Safety of Denosumab Produced by Two Different Processes in Postmenopausal Women With Osteoporosis
Status: Enrolling
Updated: 4/11/2017
mi
from
Vancouver,
Click here to add this to my saved trials
Twenty Four Month Extension Study of BA058-05-003
An Extension Study to Evaluate 24 Months of Standard-of-Care Osteoporosis Management Following Completion of 18 Months of BA058 (Abaloparatide) or Placebo Treatment in Protocol BA058-05-003
Status: Enrolling
Updated:  4/12/2017
Clinical Research Facility
mi
from
NMiami, FL
Twenty Four Month Extension Study of BA058-05-003
An Extension Study to Evaluate 24 Months of Standard-of-Care Osteoporosis Management Following Completion of 18 Months of BA058 (Abaloparatide) or Placebo Treatment in Protocol BA058-05-003
Status: Enrolling
Updated: 4/12/2017
Clinical Research Facility
mi
from
NMiami, FL
Click here to add this to my saved trials
Twenty Four Month Extension Study of BA058-05-003
An Extension Study to Evaluate 24 Months of Standard-of-Care Osteoporosis Management Following Completion of 18 Months of BA058 (Abaloparatide) or Placebo Treatment in Protocol BA058-05-003
Status: Enrolling
Updated:  4/12/2017
Clinical Research Facility
mi
from
Atlanta, GA
Twenty Four Month Extension Study of BA058-05-003
An Extension Study to Evaluate 24 Months of Standard-of-Care Osteoporosis Management Following Completion of 18 Months of BA058 (Abaloparatide) or Placebo Treatment in Protocol BA058-05-003
Status: Enrolling
Updated: 4/12/2017
Clinical Research Facility
mi
from
Atlanta, GA
Click here to add this to my saved trials
Twenty Four Month Extension Study of BA058-05-003
An Extension Study to Evaluate 24 Months of Standard-of-Care Osteoporosis Management Following Completion of 18 Months of BA058 (Abaloparatide) or Placebo Treatment in Protocol BA058-05-003
Status: Enrolling
Updated:  4/12/2017
Clinical Research Facility
mi
from
Bethesda, MD
Twenty Four Month Extension Study of BA058-05-003
An Extension Study to Evaluate 24 Months of Standard-of-Care Osteoporosis Management Following Completion of 18 Months of BA058 (Abaloparatide) or Placebo Treatment in Protocol BA058-05-003
Status: Enrolling
Updated: 4/12/2017
Clinical Research Facility
mi
from
Bethesda, MD
Click here to add this to my saved trials
Twenty Four Month Extension Study of BA058-05-003
An Extension Study to Evaluate 24 Months of Standard-of-Care Osteoporosis Management Following Completion of 18 Months of BA058 (Abaloparatide) or Placebo Treatment in Protocol BA058-05-003
Status: Enrolling
Updated:  4/12/2017
Clinical Research Facility
mi
from
Lakewood, CO
Twenty Four Month Extension Study of BA058-05-003
An Extension Study to Evaluate 24 Months of Standard-of-Care Osteoporosis Management Following Completion of 18 Months of BA058 (Abaloparatide) or Placebo Treatment in Protocol BA058-05-003
Status: Enrolling
Updated: 4/12/2017
Clinical Research Facility
mi
from
Lakewood, CO
Click here to add this to my saved trials
Twenty Four Month Extension Study of BA058-05-003
An Extension Study to Evaluate 24 Months of Standard-of-Care Osteoporosis Management Following Completion of 18 Months of BA058 (Abaloparatide) or Placebo Treatment in Protocol BA058-05-003
Status: Enrolling
Updated:  4/12/2017
mi
from
Buenos Aires,
Twenty Four Month Extension Study of BA058-05-003
An Extension Study to Evaluate 24 Months of Standard-of-Care Osteoporosis Management Following Completion of 18 Months of BA058 (Abaloparatide) or Placebo Treatment in Protocol BA058-05-003
Status: Enrolling
Updated: 4/12/2017
mi
from
Buenos Aires,
Click here to add this to my saved trials
Communication & Peer Support Effects on Physical Activity in Overweight Postmenopausal Women
A Feasibility Study on the Effects of Tailored Communication and Health Coach Support on Physical Activity in Overweight Postmenopausal Women: BePHIT
Status: Enrolling
Updated:  9/13/2017
Ohio State University Medical Center
mi
from
Columbus, OH
Communication & Peer Support Effects on Physical Activity in Overweight Postmenopausal Women
A Feasibility Study on the Effects of Tailored Communication and Health Coach Support on Physical Activity in Overweight Postmenopausal Women: BePHIT
Status: Enrolling
Updated: 9/13/2017
Ohio State University Medical Center
mi
from
Columbus, OH
Click here to add this to my saved trials
Fulvestrant and Anastrozole as Consolidation Therapy in Postmenopausal Women With Advanced Non-small Cell Lung Cancer
A Phase II Randomized Trial of Fulvestrant and Anastrozole as Consolidation Therapy in Postmenopausal Women With Advanced Non-small Cell Lung Cancer Who Have Received First-line Platinum-based Chemotherapy With or Without Bevacizumab
Status: Enrolling
Updated:  9/18/2017
University of Pittsburgh Cancer Institute
mi
from
Pittsburgh, PA
Fulvestrant and Anastrozole as Consolidation Therapy in Postmenopausal Women With Advanced Non-small Cell Lung Cancer
A Phase II Randomized Trial of Fulvestrant and Anastrozole as Consolidation Therapy in Postmenopausal Women With Advanced Non-small Cell Lung Cancer Who Have Received First-line Platinum-based Chemotherapy With or Without Bevacizumab
Status: Enrolling
Updated: 9/18/2017
University of Pittsburgh Cancer Institute
mi
from
Pittsburgh, PA
Click here to add this to my saved trials
VERtebral Fracture Treatment Comparisons in Osteoporotic Women
Teriparatide and Risedronate in the Treatment of Patients With Severe Postmenopausal Osteoporosis: Comparative Effects on Vertebral Fractures
Status: Enrolling
Updated:  12/20/2017
Clinical Research Facility
mi
from
Birmingham, AL
VERtebral Fracture Treatment Comparisons in Osteoporotic Women
Teriparatide and Risedronate in the Treatment of Patients With Severe Postmenopausal Osteoporosis: Comparative Effects on Vertebral Fractures
Status: Enrolling
Updated: 12/20/2017
Clinical Research Facility
mi
from
Birmingham, AL
Click here to add this to my saved trials
VERtebral Fracture Treatment Comparisons in Osteoporotic Women
Teriparatide and Risedronate in the Treatment of Patients With Severe Postmenopausal Osteoporosis: Comparative Effects on Vertebral Fractures
Status: Enrolling
Updated:  12/20/2017
Clinical Research Facility
mi
from
Concord, CA
VERtebral Fracture Treatment Comparisons in Osteoporotic Women
Teriparatide and Risedronate in the Treatment of Patients With Severe Postmenopausal Osteoporosis: Comparative Effects on Vertebral Fractures
Status: Enrolling
Updated: 12/20/2017
Clinical Research Facility
mi
from
Concord, CA
Click here to add this to my saved trials
VERtebral Fracture Treatment Comparisons in Osteoporotic Women
Teriparatide and Risedronate in the Treatment of Patients With Severe Postmenopausal Osteoporosis: Comparative Effects on Vertebral Fractures
Status: Enrolling
Updated:  12/20/2017
Clinical Research Facility
mi
from
Fresno, CA
VERtebral Fracture Treatment Comparisons in Osteoporotic Women
Teriparatide and Risedronate in the Treatment of Patients With Severe Postmenopausal Osteoporosis: Comparative Effects on Vertebral Fractures
Status: Enrolling
Updated: 12/20/2017
Clinical Research Facility
mi
from
Fresno, CA
Click here to add this to my saved trials
VERtebral Fracture Treatment Comparisons in Osteoporotic Women
Teriparatide and Risedronate in the Treatment of Patients With Severe Postmenopausal Osteoporosis: Comparative Effects on Vertebral Fractures
Status: Enrolling
Updated:  12/20/2017
Clinical Research Facility
mi
from
Laguna Hills, CA
VERtebral Fracture Treatment Comparisons in Osteoporotic Women
Teriparatide and Risedronate in the Treatment of Patients With Severe Postmenopausal Osteoporosis: Comparative Effects on Vertebral Fractures
Status: Enrolling
Updated: 12/20/2017
Clinical Research Facility
mi
from
Laguna Hills, CA
Click here to add this to my saved trials
VERtebral Fracture Treatment Comparisons in Osteoporotic Women
Teriparatide and Risedronate in the Treatment of Patients With Severe Postmenopausal Osteoporosis: Comparative Effects on Vertebral Fractures
Status: Enrolling
Updated:  12/20/2017
Clinical Research Facility
mi
from
Lancaster, CA
VERtebral Fracture Treatment Comparisons in Osteoporotic Women
Teriparatide and Risedronate in the Treatment of Patients With Severe Postmenopausal Osteoporosis: Comparative Effects on Vertebral Fractures
Status: Enrolling
Updated: 12/20/2017
Clinical Research Facility
mi
from
Lancaster, CA
Click here to add this to my saved trials
VERtebral Fracture Treatment Comparisons in Osteoporotic Women
Teriparatide and Risedronate in the Treatment of Patients With Severe Postmenopausal Osteoporosis: Comparative Effects on Vertebral Fractures
Status: Enrolling
Updated:  12/20/2017
Clinical Research Facility
mi
from
Tustin, CA
VERtebral Fracture Treatment Comparisons in Osteoporotic Women
Teriparatide and Risedronate in the Treatment of Patients With Severe Postmenopausal Osteoporosis: Comparative Effects on Vertebral Fractures
Status: Enrolling
Updated: 12/20/2017
Clinical Research Facility
mi
from
Tustin, CA
Click here to add this to my saved trials
VERtebral Fracture Treatment Comparisons in Osteoporotic Women
Teriparatide and Risedronate in the Treatment of Patients With Severe Postmenopausal Osteoporosis: Comparative Effects on Vertebral Fractures
Status: Enrolling
Updated:  12/20/2017
Clinical Research Facility
mi
from
Lakewood, CO
VERtebral Fracture Treatment Comparisons in Osteoporotic Women
Teriparatide and Risedronate in the Treatment of Patients With Severe Postmenopausal Osteoporosis: Comparative Effects on Vertebral Fractures
Status: Enrolling
Updated: 12/20/2017
Clinical Research Facility
mi
from
Lakewood, CO
Click here to add this to my saved trials
VERtebral Fracture Treatment Comparisons in Osteoporotic Women
Teriparatide and Risedronate in the Treatment of Patients With Severe Postmenopausal Osteoporosis: Comparative Effects on Vertebral Fractures
Status: Enrolling
Updated:  12/20/2017
Clinical Research Facility
mi
from
Danbury, CT
VERtebral Fracture Treatment Comparisons in Osteoporotic Women
Teriparatide and Risedronate in the Treatment of Patients With Severe Postmenopausal Osteoporosis: Comparative Effects on Vertebral Fractures
Status: Enrolling
Updated: 12/20/2017
Clinical Research Facility
mi
from
Danbury, CT
Click here to add this to my saved trials
VERtebral Fracture Treatment Comparisons in Osteoporotic Women
Teriparatide and Risedronate in the Treatment of Patients With Severe Postmenopausal Osteoporosis: Comparative Effects on Vertebral Fractures
Status: Enrolling
Updated:  12/20/2017
Clinical Research Facility
mi
from
Orlando, FL
VERtebral Fracture Treatment Comparisons in Osteoporotic Women
Teriparatide and Risedronate in the Treatment of Patients With Severe Postmenopausal Osteoporosis: Comparative Effects on Vertebral Fractures
Status: Enrolling
Updated: 12/20/2017
Clinical Research Facility
mi
from
Orlando, FL
Click here to add this to my saved trials
VERtebral Fracture Treatment Comparisons in Osteoporotic Women
Teriparatide and Risedronate in the Treatment of Patients With Severe Postmenopausal Osteoporosis: Comparative Effects on Vertebral Fractures
Status: Enrolling
Updated:  12/20/2017
Clinical Research Facility
mi
from
Gainesville, GA
VERtebral Fracture Treatment Comparisons in Osteoporotic Women
Teriparatide and Risedronate in the Treatment of Patients With Severe Postmenopausal Osteoporosis: Comparative Effects on Vertebral Fractures
Status: Enrolling
Updated: 12/20/2017
Clinical Research Facility
mi
from
Gainesville, GA
Click here to add this to my saved trials
VERtebral Fracture Treatment Comparisons in Osteoporotic Women
Teriparatide and Risedronate in the Treatment of Patients With Severe Postmenopausal Osteoporosis: Comparative Effects on Vertebral Fractures
Status: Enrolling
Updated:  12/20/2017
Clinical Research Facility
mi
from
Evansville, IN
VERtebral Fracture Treatment Comparisons in Osteoporotic Women
Teriparatide and Risedronate in the Treatment of Patients With Severe Postmenopausal Osteoporosis: Comparative Effects on Vertebral Fractures
Status: Enrolling
Updated: 12/20/2017
Clinical Research Facility
mi
from
Evansville, IN
Click here to add this to my saved trials
VERtebral Fracture Treatment Comparisons in Osteoporotic Women
Teriparatide and Risedronate in the Treatment of Patients With Severe Postmenopausal Osteoporosis: Comparative Effects on Vertebral Fractures
Status: Enrolling
Updated:  12/20/2017
Clinical Research Facility
mi
from
Indianapolis, IN
VERtebral Fracture Treatment Comparisons in Osteoporotic Women
Teriparatide and Risedronate in the Treatment of Patients With Severe Postmenopausal Osteoporosis: Comparative Effects on Vertebral Fractures
Status: Enrolling
Updated: 12/20/2017
Clinical Research Facility
mi
from
Indianapolis, IN
Click here to add this to my saved trials
VERtebral Fracture Treatment Comparisons in Osteoporotic Women
Teriparatide and Risedronate in the Treatment of Patients With Severe Postmenopausal Osteoporosis: Comparative Effects on Vertebral Fractures
Status: Enrolling
Updated:  12/20/2017
Clinical Research Facility
mi
from
Topeka, KA
VERtebral Fracture Treatment Comparisons in Osteoporotic Women
Teriparatide and Risedronate in the Treatment of Patients With Severe Postmenopausal Osteoporosis: Comparative Effects on Vertebral Fractures
Status: Enrolling
Updated: 12/20/2017
Clinical Research Facility
mi
from
Topeka, KA
Click here to add this to my saved trials
VERtebral Fracture Treatment Comparisons in Osteoporotic Women
Teriparatide and Risedronate in the Treatment of Patients With Severe Postmenopausal Osteoporosis: Comparative Effects on Vertebral Fractures
Status: Enrolling
Updated:  12/20/2017
Clinical Research Facility
mi
from
Bethesda, MD
VERtebral Fracture Treatment Comparisons in Osteoporotic Women
Teriparatide and Risedronate in the Treatment of Patients With Severe Postmenopausal Osteoporosis: Comparative Effects on Vertebral Fractures
Status: Enrolling
Updated: 12/20/2017
Clinical Research Facility
mi
from
Bethesda, MD
Click here to add this to my saved trials
VERtebral Fracture Treatment Comparisons in Osteoporotic Women
Teriparatide and Risedronate in the Treatment of Patients With Severe Postmenopausal Osteoporosis: Comparative Effects on Vertebral Fractures
Status: Enrolling
Updated:  12/20/2017
Clinical Research Facility
mi
from
Detroit, MI
VERtebral Fracture Treatment Comparisons in Osteoporotic Women
Teriparatide and Risedronate in the Treatment of Patients With Severe Postmenopausal Osteoporosis: Comparative Effects on Vertebral Fractures
Status: Enrolling
Updated: 12/20/2017
Clinical Research Facility
mi
from
Detroit, MI
Click here to add this to my saved trials
VERtebral Fracture Treatment Comparisons in Osteoporotic Women
Teriparatide and Risedronate in the Treatment of Patients With Severe Postmenopausal Osteoporosis: Comparative Effects on Vertebral Fractures
Status: Enrolling
Updated:  12/20/2017
Clinical Research Facility
mi
from
Omaha, NE
VERtebral Fracture Treatment Comparisons in Osteoporotic Women
Teriparatide and Risedronate in the Treatment of Patients With Severe Postmenopausal Osteoporosis: Comparative Effects on Vertebral Fractures
Status: Enrolling
Updated: 12/20/2017
Clinical Research Facility
mi
from
Omaha, NE
Click here to add this to my saved trials
VERtebral Fracture Treatment Comparisons in Osteoporotic Women
Teriparatide and Risedronate in the Treatment of Patients With Severe Postmenopausal Osteoporosis: Comparative Effects on Vertebral Fractures
Status: Enrolling
Updated:  12/20/2017
Clinical Research Facility
mi
from
Clifton, NJ
VERtebral Fracture Treatment Comparisons in Osteoporotic Women
Teriparatide and Risedronate in the Treatment of Patients With Severe Postmenopausal Osteoporosis: Comparative Effects on Vertebral Fractures
Status: Enrolling
Updated: 12/20/2017
Clinical Research Facility
mi
from
Clifton, NJ
Click here to add this to my saved trials
VERtebral Fracture Treatment Comparisons in Osteoporotic Women
Teriparatide and Risedronate in the Treatment of Patients With Severe Postmenopausal Osteoporosis: Comparative Effects on Vertebral Fractures
Status: Enrolling
Updated:  12/20/2017
Clinical Research Facility
mi
from
Freehold, NJ
VERtebral Fracture Treatment Comparisons in Osteoporotic Women
Teriparatide and Risedronate in the Treatment of Patients With Severe Postmenopausal Osteoporosis: Comparative Effects on Vertebral Fractures
Status: Enrolling
Updated: 12/20/2017
Clinical Research Facility
mi
from
Freehold, NJ
Click here to add this to my saved trials
VERtebral Fracture Treatment Comparisons in Osteoporotic Women
Teriparatide and Risedronate in the Treatment of Patients With Severe Postmenopausal Osteoporosis: Comparative Effects on Vertebral Fractures
Status: Enrolling
Updated:  12/20/2017
Clinical Research Facility
mi
from
Albuquerque, NM
VERtebral Fracture Treatment Comparisons in Osteoporotic Women
Teriparatide and Risedronate in the Treatment of Patients With Severe Postmenopausal Osteoporosis: Comparative Effects on Vertebral Fractures
Status: Enrolling
Updated: 12/20/2017
Clinical Research Facility
mi
from
Albuquerque, NM
Click here to add this to my saved trials
VERtebral Fracture Treatment Comparisons in Osteoporotic Women
Teriparatide and Risedronate in the Treatment of Patients With Severe Postmenopausal Osteoporosis: Comparative Effects on Vertebral Fractures
Status: Enrolling
Updated:  12/20/2017
Clinical Research Facility
mi
from
Asheville, NC
VERtebral Fracture Treatment Comparisons in Osteoporotic Women
Teriparatide and Risedronate in the Treatment of Patients With Severe Postmenopausal Osteoporosis: Comparative Effects on Vertebral Fractures
Status: Enrolling
Updated: 12/20/2017
Clinical Research Facility
mi
from
Asheville, NC
Click here to add this to my saved trials